NextSeq 2000 Silver Support Plan
ID: NOI-NIAID-25-2244936Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

Electronic and Precision Equipment Repair and Maintenance (811210)

PSC

MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT (J066)

Original Source

https://sam.gov/opp/9784c0aaf3fa42c49f4d3293745dd7a0/view
Timeline
    Description

    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to procure a NextSeq 2000 Silver Support Plan from Illumina, Inc. This procurement is essential for maintaining high throughput sequencing capabilities that are critical for research into immune responses against infectious diseases, particularly through RNA sequencing methods. The support plan includes comprehensive service coverage, preventive maintenance, remote technical support, and timely on-site response during the performance period from November 1, 2024, to July 4, 2025. Interested parties must submit capability statements by October 28, 2024, to Angela Puddy at angela.puddy@nih.gov, as this is not a request for proposals and the Government retains discretion regarding competition for this requirement.

    Files
    Title
    Posted
    2_NOI-NIAID-25-2244936.pdf
    The National Institute of Allergy and Infectious Diseases (NIAID) plans to procure a NextSeq 2000 Silver Support Plan from Illumina, Inc., under a sole-source justification. This plan is essential for maintaining high throughput sequencing capabilities crucial for their research into immune responses against infectious diseases, particularly using RNA sequencing methods. The minimum requirements include comprehensive service coverage, preventive maintenance, remote technical support, and timely on-site response during the support period of November 1, 2024, to July 4, 2025. The notice highlights the necessity for service providers to demonstrate authorization as authorized providers for Illumina equipment. Interested parties must submit capability statements by October 28, 2024. The document clarifies that this is not a request for proposals and emphasizes the Government's discretion regarding competition for this requirement.
    Lifecycle
    Title
    Type
    NextSeq 2000 Silver Support Plan
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    MAINTENANCE AND REPAIR SERVICE AGREEMENT FOR NEXTSEQ 2000 (S/N: VH74007)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to negotiate a maintenance and repair service agreement for the Illumina NextSeq 2000 system, serial number VH74007. The contract will cover a 12-month support plan, including full maintenance for parts, labor, and travel, as well as preventative maintenance inspections, remote technical support, and software updates. This service is crucial for the Laboratory of Parasitic Diseases to ensure the operational efficiency of their sequencing equipment. Interested vendors must submit their capability statements and relevant documentation by 12:00 PM EST on November 15, 2024, via the NIH electronic Simplified Acquisition Submission System (eSASS), with all inquiries directed to Mildred Moss at mildred.moss@nih.gov or Tonia Alexander at talexander@niaid.nih.gov.
    Maintenance Service for two (2) Illumina NextSeq™ 1000 Sequencers
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Illumina, Inc. for maintenance services on two Illumina NextSeq™ 1000 Sequencers. The contract will cover comprehensive support, including parts, labor, travel, and technical assistance, essential for high-throughput next-generation sequencing used in diagnosing inherited immune disorders. This acquisition is critical as Illumina is the sole manufacturer with the necessary components and expertise to maintain the equipment to its original specifications. Interested parties capable of providing similar services may submit a capability statement to Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov, with submissions due by the specified deadline.
    10x Genomics Xenium Analyzer Maintenance Plan
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is planning to award a Firm-Fixed Price purchase order to 10X Genomics, Inc. for the maintenance of the 10x Genomics Xenium instrument, which is critical for clustering single-cell genetic material on tissue sections. This maintenance plan aims to ensure the instrument remains operational and minimizes downtime during repair requests, as 10X Genomics is the sole manufacturer and provider of maintenance support for this proprietary technology. Interested parties who believe they can meet the requirements are invited to submit a written capability statement by 12 p.m. EST on Tuesday, October 29, 2024, to Zetherine Gore at zetherine.gore@nih.gov, referencing Notice ID SS-NIH-7095584 in their correspondence.
    CareDX Lab Solutions Inc. Allo Seq Tx17 Next Generation Sequencing (NGS) Reagent Kits
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to issue a sole source firm fixed-price purchase order to CareDx Lab Solutions Inc. for the procurement of Allo Seq Tx17 Next Generation Sequencing (NGS) reagent kits. This acquisition aims to secure a one-year supply of NGS reagents necessary for the Human Leukocyte Antigen (HLA) Laboratory within the Department of Transfusion Medicine, ensuring adequate stock for patient testing through quarterly shipments scheduled from November 2024 to August 2025. The HLA Laboratory plays a critical role in providing diagnostic testing and consultations for transplant eligibility, maintaining accreditation, and engaging in research for new diagnostic tests. Interested parties may submit their capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by October 30, 2024, at 6:30 AM EST, as this is not a request for proposals.
    cDNA-PCR Sequencing Kits for long-read sequencing.
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information from qualified sources regarding the availability of cDNA-PCR sequencing kits for long-read sequencing, as part of a Sources Sought notice. The primary objective is to procure PromethION flow cells and sequencing kits that are compatible with the Oxford Nanopore PromethION device, which is essential for high-throughput sequencing in research on Alzheimer’s disease and related dementias. These consumables will facilitate the analysis of DNA and RNA samples, aiding in the identification of potential therapeutic targets and biomarkers for Alzheimer's disease. Interested companies must submit their capability statements by October 28, 2024, at 5 PM Eastern Time, to Iris Merscher at iris.merscher@nih.gov, ensuring that all submissions adhere to the specified guidelines and page limits.
    Maintenance Support for Flow Cytometry Equipment
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for maintenance support services for the BD Biosciences FACSDiscover S8 flow cytometry equipment. The contractor will be responsible for providing comprehensive maintenance, including parts, labor, and unlimited service calls, ensuring the equipment remains operational for critical biomedical research. This procurement is vital for maintaining the functionality of essential laboratory instruments, with the anticipated contract period from November 27, 2024, to November 26, 2025, and options for two additional years. Interested parties must submit their quotations by 9:00 a.m. Eastern Daylight Time on October 30, 2024, to Emily Palombo at emily.palombo@nih.gov.
    Renewal of maintenance/service agreement for medical diagnostic imaging equipment
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole source contract with Philips North America LLC for the renewal of a maintenance/service agreement for medical diagnostic imaging equipment at the Integrated Research Facility (IRF) in Frederick, Maryland. This agreement is crucial for maintaining the operational integrity of specialized imaging equipment, including a Magnetic Resonance 3T Achieva and associated workstations, which are essential for conducting biodefense research involving high-consequence infectious diseases. The contract is set to cover the period from January 18, 2025, to December 31, 2025, coinciding with the end of the equipment's life cycle, and interested vendors may submit capability statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by October 25, 2024, at 5:00 PM ET. For further inquiries, contact Dana Monroe at dana.monroe@nih.gov or call 406-375-9814.
    SERVICE AGREEMENT FOR MOSQUITO LCP, DRAGONFLY CRYSTAL 5 HEAD AND MX ONE MIXER
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for a service agreement for the Mosquito LCP, Dragonfly Crystal 5 Head, and MX One Mixer, essential laboratory equipment used in research and development. The contract requires comprehensive maintenance services, including a four-hour initial response time, two-day onsite support, annual preventative maintenance, and unlimited remote assistance, ensuring the operational efficiency of critical research tools. This procurement is vital for maintaining the functionality of equipment that supports the NIH's mission in allergy and infectious disease research. Interested vendors must submit their quotations by November 1, 2024, at 12:00 am EST, and can contact Maliaka Pinkney at maliaka.pinkney@nih.gov or Jesse D Weidow at weidowjd@niaid.nih.gov for further information.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    Qiagen LLC DNA Isolation Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure DNA Isolation Kits from Qiagen LLC on a sole source basis. The acquisition aims to supply the Human Leukocyte Antigen (HLA) Lab with essential testing kits that have been rigorously tested to ensure high-quality DNA samples for critical patient testing. These kits are vital for HLA typing, particularly for critically ill patients, as they directly impact the turnaround time for results necessary for lifesaving transplants. Interested parties may submit their capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by October 31, 2024, at 6:30 AM EST, as this is not a request for proposals.